All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Alzheimer's disease and blood-based biomarkers - potential contexts of use

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10377524" target="_blank" >RIV/00216208:11110/18:10377524 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/18:10377524

  • Result on the web

    <a href="https://doi.org/10.2147/NDT.S172285" target="_blank" >https://doi.org/10.2147/NDT.S172285</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.2147/NDT.S172285" target="_blank" >10.2147/NDT.S172285</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Alzheimer's disease and blood-based biomarkers - potential contexts of use

  • Original language description

    Alzheimer&apos;s disease (AD) is an irreversible, incurable, progressive neurodegenerative illness, where dementia symptoms gradually worsen over a number of years. The research of validated biomarkers for AD is essential to improve diagnosis and accelerate the development of new therapies. Biochemical markers including neuroimaging could facilitate diagnosis, predict AD progression from a pre-AD state of mild cognitive impairment, and be used to detect the efficacies of disease-modifying therapies. Established biomarkers of AD from cerebrospinal fluid and neuroimaging are highly accurate, but barriers to clinical implementation exist. The focus on blood-based AD biomarkers has grown exponentially during the past few decades. An ideal diagnostic test for AD should be noninvasive and easily applicable. Clinical cost-effectiveness also needs to be established.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30215 - Psychiatry

Result continuities

  • Project

    <a href="/en/project/GA17-05292S" target="_blank" >GA17-05292S: Novel blood-based biomarkers for early diagnosis, prognosis and progress of Alzheimer's disease</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Neuropsychiatric Disease and Treatment

  • ISSN

    1178-2021

  • e-ISSN

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    July

  • Country of publishing house

    NZ - NEW ZEALAND

  • Number of pages

    6

  • Pages from-to

    1877-1882

  • UT code for WoS article

    000439511300002

  • EID of the result in the Scopus database

    2-s2.0-85057543947